Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | HNO3 |
| Molecular Weight | 63.0128 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O[N+]([O-])=O
InChI
InChIKey=GRYLNZFGIOXLOG-UHFFFAOYSA-N
InChI=1S/HNO3/c2-1(3)4/h(H,2,3,4)
| Molecular Formula | HNO3 |
| Molecular Weight | 63.0128 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Nitrate ion (NO3 −) is found naturally in the environment and is an important plant nutrient. It is present at varying concentrations in all plants and is a part of the nitrogen cycle. Nitrate probably has a role in protecting the gastrointestinal tract against a variety of gastrointestinal pathogens, as nitrous oxide and acidified nitrite have antibacterial properties. Significant bacterial reduction of nitrate to nitrite does not normally take place in the stomach, except in individuals with low gastric acidity or with gastrointestinal infections. These may include individuals using antacids, particularly those that block acid secretion. Potassium nitrate is used as mild local desensitizer in toothpastes.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| NOS2 is critical to the development of emphysema in Sftpd deficient mice but does not affect surfactant homeostasis. | 2014 |
|
| Fine particulate matter constituents and cardiopulmonary mortality in a heavily polluted Chinese city. | 2012-03 |
|
| Reduced systemic vascular resistance in healthy volunteers with presyncopal symptoms during a nitrate-stimulated tilt-table test. | 2011-01 |
|
| Goitrogenic anions, thyroid-stimulating hormone, and thyroid hormone in infants. | 2010-09 |
|
| Fatal pulmonary edema after acute occupational exposure to nitric acid. | 2010-07 |
|
| The nitric acid burn trauma of the skin. | 2010-04 |
|
| Relationship between endogenous concentrations of vasoactive substances and measures of peripheral vasodilator function in patients with coronary artery disease. | 2010-01 |
|
| Management of unusually extensive esophagogastric corrosive injuries: emergency measures and gastric reconstruction. | 2009-05 |
|
| Acute lung injury after inhalation of nitric acid. | 2008-12 |
|
| An unusual circumstance of internal chemical burn injury - a case report. | 2008-10 |
|
| Water disinfection by-products and pre-labor rupture of membranes. | 2008-09-01 |
|
| Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases. | 2008-09 |
|
| Synthesis, pharmacological activity and nitric oxide generation by nitrate derivatives of theophylline. | 2008-05 |
|
| Successful extracorporeal life support after potentially fatal pulmonary oedema caused by inhalation of nitric and hydrofluoric acid fumes. | 2007-10 |
|
| Modifications of inflammatory pathways in rat intestine following chronic ingestion of depleted uranium. | 2007-08 |
|
| Oxidative and nitrosative stress in acute ischaemic stroke. | 2007-01 |
|
| Serofendic acid, a substance extracted from fetal calf serum, as a novel drug for cardioprotection. | 2007 |
|
| Blockade of endothelin ET(A)/ET(B) receptors favors a role for endothelin during acute Trypanosoma cruzi infection in rats. | 2006-07 |
|
| Evaluation of possible goitrogenic and anti-thyroidal effect of nitrate, a potential environmental pollutant. | 2006-01-31 |
|
| Immune cell infiltration and broncovascular remodeling after nitric acid nasal instillation in a mouse bronchiolitis obliterans model. | 2006-01-07 |
|
| Clinical diagnostic indicators of renal and bone damage in rats intramuscularly injected with depleted uranium. | 2006 |
|
| Cl- interference with the epithelial Na+ channel ENaC. | 2005-09-09 |
|
| Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. | 2005-08 |
|
| Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate. | 2005-02-01 |
|
| [Clinical observation on acupuncture combined with medication for intractable angina pectoris]. | 2005-02 |
|
| Role of tumor necrosis factor-alpha in down-regulation of hepatic cytochrome P450 and P-glycoprotein by endotoxin. | 2005-01-10 |
|
| Rate and extent of percutaneous absorption of sertaconazole nitrate after topical administration. | 2005 |
|
| Epidemiology of 377 patients with chemical burns in Guangdong province. | 2004-09 |
|
| Nitric acid-induced bronchiolitis in rats mimics childhood Bronchiolitis obliterans. | 2004-08-12 |
|
| Acute gastric perforation after acid ingestion. | 2002-09 |
|
| Respiratory tract responses to repeated inhalation of an oxidant and acid gas-particle air pollutant mixture. | 2001-06 |
|
| [Upper gastrointestinal tract injury caused by ingestion of caustic substances]. | 2001-04 |
|
| Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP. | 1999-01-05 |
|
| The assimilatory nitrate reductase from the phototrophic bacterium, Rhodobacter capsulatus E1F1, is a flavoprotein. | 1997-09-01 |
|
| Serum and tissue nitrate levels in murine visceral leishmaniasis correlate with parasite load but not with host protection. | 1997-07-01 |
|
| Incidence of childhood diabetes mellitus in Yorkshire, northern England, is associated with nitrate in drinking water: an ecological analysis. | 1997-05 |
|
| Prevention by morphine of apomorphine- and oxytocin-induced penile erection and yawning: involvement of nitric oxide. | 1997-05 |
|
| Therapy of angina pectoris with long-acting nitrates: which agent and when? | 1996-05 |
|
| Dipyridamole enhances interleukin-1beta-stimulated nitric oxide production by cultured rat vascular smooth muscle cells. | 1996-02-05 |
|
| Transient reversal of blood flow in an internal thoracic artery to coronary artery graft during syncope. | 1994-08 |
|
| [Anti-angina therapy of coronary heart disease. Mono- or combination treatment]. | 1991-05 |
|
| [Drug treatment of myocardial ischemia]. | 1991 |
|
| Nitrates in acute myocardial infarction. | 1987 |
|
| Drug-induced torsade de pointes. | 1985-11-01 |
|
| Addition of nifedipine to maximal nitrate and beta-adrenoreceptor blocker therapy in coronary artery disease. | 1985-05-01 |
|
| Calcium antagonists. | 1985 |
|
| Acquired methemoglobinemia and hemolytic anemia after usual doses of phenazopyridine. | 1982-02 |
|
| [Acute and chronic cardiac decompensation: is vasodilator therapy useful?]. | 1982-01-14 |
|
| Electrophysiologic properties of hydralazine in man. | 1980-09 |
|
| Proton translocation and the respiratory nitrate reductase of Escherichia coli. | 1975-12 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:06:51 GMT 2025
by
admin
on
Mon Mar 31 18:06:51 GMT 2025
|
| Record UNII |
411VRN1TV4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C802
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
||
|
EPA PESTICIDE CODE |
45951
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL1352
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | |||
|
48107
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | |||
|
NITRIC ACID
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | |||
|
1665
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | |||
|
411VRN1TV4
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | |||
|
944
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | |||
|
7697-37-2
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | |||
|
D017942
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | |||
|
100000080017
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | |||
|
SUB14657MIG
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | |||
|
DTXSID5029685
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | |||
|
1311391
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | RxNorm | ||
|
C28202
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | |||
|
411VRN1TV4
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | |||
|
231-714-2
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | |||
|
m7933
Created by
admin on Mon Mar 31 18:06:51 GMT 2025 , Edited by admin on Mon Mar 31 18:06:51 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|